Wednesday, 7 December 2011: 15:45 - 16:05
Costa Maya 2 (Cancún Center)
Bruce Bochner, MD
,
Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD
Learning Objectives:
1. Review current approved therapies that are capable of reducing eosinophils.
1. Review current approved therapies that are capable of reducing eosinophils.
2. Describe agents in clinical trials that target eosinophils.
3. Explain novel preclinical therapies that might some day be useful for treating eosinophilic disorders.